Isolation of farnesyltransferase inhibitors from herbal medicines

被引:5
作者
Kwon, BM [1 ]
Lee, SH [1 ]
Kim, MJ [1 ]
Kim, HK [1 ]
Kim, HM [1 ]
机构
[1] KRIBB, Taejon 305600, South Korea
来源
ANTICANCER MOLECULES: STRUCTURE, FUNCTION, AND DESIGN | 1999年 / 886卷
关键词
D O I
10.1111/j.1749-6632.1999.tb09431.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
引用
收藏
页码:261 / 264
页数:4
相关论文
共 7 条
[1]   Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways [J].
Arbiser, JL ;
Moses, MA ;
Fernandez, CA ;
Ghiso, N ;
Cao, YH ;
Klauber, N ;
Frank, D ;
Brownlee, M ;
Flynn, E ;
Parangi, S ;
Byers, HR ;
Folkman, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (03) :861-866
[2]   FARNESYLTRANSFERASE INHIBITORS - RAS RESEARCH YIELDS A POTENTIAL CANCER THERAPEUTIC [J].
GIBBS, JB ;
OLIFF, A ;
KOHL, NE .
CELL, 1994, 77 (02) :175-178
[3]   BIOLOGICAL-ACTIVITIES OF SESQUITERPENE LACTONES [J].
PICMAN, AK .
BIOCHEMICAL SYSTEMATICS AND ECOLOGY, 1986, 14 (03) :255-281
[4]  
Qian YM, 1997, BIOPOLYMERS, V43, P25, DOI 10.1002/(SICI)1097-0282(1997)43:1<25::AID-BIP4>3.0.CO
[5]  
2-2
[6]   New approaches to anticancer drug design based on the inhibition of farnesyltransferase [J].
Sebti, SM ;
Hamilton, AD .
DRUG DISCOVERY TODAY, 1998, 3 (01) :26-33
[7]   Signaling pathways in Ras-mediated tumorigenicity and metastasis [J].
Webb, CP ;
Van Aelst, L ;
Wigler, MH ;
Vande Woude, GF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (15) :8773-8778